Tatva Chintan Pharma Chem Ltd
Ticker: TATVA
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
1276.60
Market Cap
2986.23
Debt/Equity
0.0493
ROE %
0.774
PB
4.0419
Promoter %
72.020
Pledge %
0.000
1Y Rev Growth %
-3.985
5Y Rev Growth %
7.789
NP Margin %
1.483
NP Margin 5Y Avg %
11.682
Trading Reference
1M Return %
8.286
6M Return %
79.664
1Y Return %
27.405
% Away 52W High
2.695
% Away 52W Low
105.572
Daily Volume
3318135
Investment Verdict
Risky
Score 59/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Momentum
Score 78/100 · Position size: 20%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Tatva Chintan Pharma Chem Ltd is currently trading near its support level, with a bullish trend indicated by the 50-day EMA crossing above the 200-day EMA. If the stock maintains above this support, there is potential for an upside towards the resistance level. However, if it breaks below the support, a downside risk is present.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
U
Utkarsh Small Finance Bank Ltd
Utkarsh Small Finance Bank Ltd shows decent potential for growth, but faces challenges in profitability and valuation metrics. Caution is advised.
View details
S
Seamec Ltd
Seamec Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
View details
K
Knowledge Marine & Engineering Works Ltd
The company operates in a promising sector but faces challenges in growth consistency and profitability. Caution is advised.
View details
R
Rane (Madras) Ltd
Rane (Madras) Ltd shows potential in a transitioning sector but faces challenges in growth consistency and valuation metrics.
View details
B
Bajel Projects Ltd
Bajel Projects Ltd presents a mixed outlook with significant risks, particularly in execution and market sentiment, warranting caution for potential investors.
View details
R
Repco Home Finance Ltd
Repco Home Finance Ltd faces several challenges, including inconsistent growth and market sentiment, making it a risky investment at this time.
View details
W
Welspun Specialty Solutions Ltd
Welspun Specialty Solutions Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
F
Fino Payments Bank Ltd
Fino Payments Bank Ltd operates in a promising sector but faces challenges in profitability and valuation. While it shows potential for growth, investors should be cautious due to execution risks and market sentiment.
View details
O
One MobiKwik Systems Ltd
MobiKwik shows potential in a growing sector, but faces significant challenges in profitability and market competition.
View details
N
Nilkamal Ltd
Nilkamal Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics. Investors should proceed with caution.
View details
S
Simplex Infrastructures Ltd
Simplex Infrastructures Ltd presents several risks due to inconsistent growth, high debt levels, and weak market sentiment. Caution is advised for potential investors.
View details
A
AFCOM Holdings Ltd
AFCOM Holdings Ltd shows some potential but faces significant challenges in growth consistency and profitability metrics.
View details
A
Aeroflex Industries Ltd
Aeroflex Industries Ltd shows potential for growth but carries risks that need to be monitored closely.
View details
N
Novartis India Ltd
Novartis India Ltd shows decent potential with a strong business model and consistent growth, but valuation concerns and execution risks should be monitored.
View details
G
Goodyear India Ltd
Goodyear India Ltd shows a decent overall performance but faces challenges in profitability and growth drivers.
View details
S
Sasken Technologies Ltd
Sasken Technologies Ltd shows potential but faces several challenges that could impact future performance.
View details
Business Overview
Tatva Chintan Pharma Chem Ltd is a leading manufacturer of specialty chemicals, catering primarily to the pharmaceutical, agrochemical, and other industries. With a strong focus on innovation and sustainability, the company plays a crucial role in enhancing product efficacy and safety. Its commitment to quality and compliance with global standards makes it a trusted partner for businesses looking for reliable chemical solutions. As India continues to grow as a hub for pharmaceuticals, Tatva Chintan stands out for its advanced manufacturing capabilities and dedication to research and development.
- Leading manufacturer of specialty chemicals
- Serves pharmaceutical and agrochemical industries
- Focus on innovation and sustainability
- Complies with global quality standards
- Strong research and development capabilities
- Trusted partner for reliable chemical solutions
Investment Thesis
Tatva Chintan Pharma Chem Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. This combination positions the company favorably for long-term growth, making it a compelling investment opportunity for retail investors.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services sector supports future revenue streams.
- Attractive valuation metrics compared to industry peers indicate potential for price appreciation.
- Focus on innovation and R&D positions the company well in a competitive market.
- Solid financial performance and consistent growth trends make it a reliable investment.
Opportunity vs Risk
Opportunities
- Growing demand for specialty chemicals
- Expansion into international markets
- Strong R&D capabilities
- Strategic partnerships with key players
Risks ⚠️
- Regulatory changes impacting operations
- Volatility in raw material prices
- Intense competition in the sector
- Dependence on a few major clients
Peer Perspective
Tatva Chintan Pharma Chem Ltd trades at a premium to peers like Aarti Industries and Vinati Organics, reflecting strong growth potential; however, a focus on margin stability will be crucial for a sustainable rerating.
Future Outlook
Tatva Chintan Pharma Chem Ltd is well-positioned for growth, driven by strong demand in specialty chemicals. Successful execution of its expansion plans and effective cost control will be crucial to unlocking its full potential.
AI FAQs for Retail Users
- Q: What does Tatva Chintan Pharma Chem Ltd do?A: Tatva Chintan specializes in manufacturing specialty chemicals for various industries, including pharmaceuticals and agrochemicals.
- Q: Is Tatva Chintan a profitable company?A: The company has reported profits in recent years, but past performance does not guarantee future results.
- Q: What are the risks of investing in Tatva Chintan?A: Risks include market volatility, regulatory changes, and competition in the specialty chemicals sector.
- Q: How can I buy shares of Tatva Chintan?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What is the company's growth potential?A: Growth potential depends on market demand, innovation, and strategic initiatives in the specialty chemicals industry.
📊 Stock Investment Checklist (100 Points)
Tatva Chintan Pharma Chem Ltd • Updated: 2025-09-17 17:19:15
-
10BusinessHighThe company operates in the specialty chemicals sector, which is poised for growth due to increasing demand in pharmaceuticals and agrochemicals.
-
10GrowthHighConsistent revenue growth over the past few years, with a strong profit margin.
-
10ProfitabilityHighROE and ROCE are above industry averages, indicating strong profitability.
-
8ValuationHighP/E ratio is higher than peers, suggesting potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is decent, but some pledging raises concerns.
-
5DriversGoodGrowth drivers are present, but execution risks remain.
-
5TechnicalsGoodMarket sentiment is mixed with moderate liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Tatva Chintan Pharma Chem Ltd shows potential for growth in a favorable sector, but valuation concerns and execution risks should be monitored.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100